Document is current

Any future updates will be listed below

Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: a subanalysis from a phase 3 trial (MPACT)

Crossref DOI link: https://doi.org/10.1186/s12885-016-2798-8

Published Online: 2016-10-21

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark